We strive to provide life-saving medicine
for people suffering from diseases,
including their families, around the world.
News
- Oct.25,2024 News release FIMECS Presents at the 7th TPD & Induced Proximity Summit
2.96 KB
- Sep.25,2024 News release Publication as a result of collaboration with Kyoto University
2.92 KB
- Jul.30,2024 News release RaQualia Group R&D Meeting Video Streaming
- Jul.22,2024 News release FIMECS Received A Notice for Patent Allowance
2.88 KB
- Jun.10,2024 News release RaQualia Group R&D Meeting on 21st July
2.80 KB
- Jun.10,2024 News release FIMECS Presents at the Frontiers of Drug Discovery 2024
2.72 KB
- May.18,2024 News release FIMECS Presents at the Protein Degradation in Focus
2.70 KB
- Mar.30,2024 News release FIMECS Presents at the 19th Annual Drug Discovery Chemistry
2.66 KB
- Mar.27,2024 News release FIMECS Appoints Two New Board Members
2.61 KB
- Mar.13,2024 News release FIMECS Presents at the 4th Annual Targeted Protein Degradation Europe Summit
2.60 KB
- Feb.14,2024 News release Acquisition of FIMECS by RaQualia Pharma
2.57 KB
- Oct.26,2023 News release FIMECS Presents at the 6th Targeted Protein Degradation Summit
2.54 KB
- Sep.18,2023 News release FIMECS Presents at The Protein Degradation & Targeting Undruggables Europe 2023 in Basel, Switzerland
2.51 KB
- Jul.31,2023 News release FIMECS Announces Resignation of Chief Financial Officer
2.48 KB
- Jul.25,2023 News release FIMECS Presents at the 2nd Targeted Protein Degradation Conference in Japan
2.46 KB
- Jun.3,2023 News release FIMECS Presents at the Discovery Europe 2023
2.44 KB
- Apr.6,2023 News release FIMECS Presents at the 3rd Annual Ligase Targeting Drug Development Summit
2.29 KB
- Mar.31,2023 News release FIMECS Appoints Mr. Masanobu Yatabe as Chief Financial Officer
2.24 KB
- Mar.28,2023 News release FIMECS Organizes 2nd Targeted Protein Degradation Conference in Japan
2.22 KB
- Mar.27,2023 News release FIMECS Presents at the 3rd Annual Targeted Protein Degradation Europe Summit
2.15 KB
Read More